Search
Neuphoria Therapeutics Inc
NEUPAdd to Watchlist
3.880USD
-0.040-1.02%
Close 07-31 16:00（ET）Quotes delayed by 15 min
20.97MMarket Cap
LossP/E TTM
Neuphoria Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-07-31The current valuation score of Neuphoria Therapeutics Inc is 8.39, ranking 102 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -0.49, which is -14.96% below the recent high of -0.42 and -17773.34% above the recent low of -87.81.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.